Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The potential therapeutic benefit of SGLT2 inhibitors in this population is very high.”
Study subgroup analyses reveal marked heart failure risk reduction with SGLT2 inhibitors in Black patients, suggesting potential to reduce health disparities.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: